Lee B. Rivera
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 5
- Cancer Cells and Metastasis 3
-
- Angiogenesis and VEGF in Cancer 6
- Co-authors
- Gabriele Bergers (7 shared papers)Rolf A. Brekken (12 shared papers)Inge Lodewijckx (1 shared paper)Rindert Missiaen (1 shared paper)Arnaud Jabouille (1 shared paper)Veronica Steri (1 shared paper)Elizabeth Allen (1 shared paper)Douglas Hanahan (1 shared paper)
- Journals
- Cancer Research (6 papers)Disease Models & Mechanisms (2 papers)Science (2 papers)The Journal of Cell Biology (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- United StatesSouth KoreaPortugal
In The Last Decade
Lee B. Rivera
20 papers receiving 1.6k citations
Lee B. Rivera's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 853
- Immunology 499
- Cancer Research 343
- Immunology and Allergy 82
- Molecular Biology 626
Countries citing papers authored by Lee B. Rivera
This map shows the geographic impact of Lee B. Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee B. Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee B. Rivera more than expected).
Fields of papers citing papers by Lee B. Rivera
This network shows the impact of papers produced by Lee B. Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee B. Rivera. The network helps show where Lee B. Rivera may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee B. Rivera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation Hit paper breakdown → | 2017 | 589 |
| 2 | 2015 | 123 | |
| 3 | 2015 | 121 | |
| 4 | 2009 | 93 | |
| 5 | 2015 | 87 | |
| 6 | 2012 | 77 | |
| 7 | 2013 | 76 | |
| 8 | 2011 | 73 | |
| 9 | 2012 | 62 | |
| 10 | 2011 | 59 | |
| 11 | 2011 | 52 | |
| 12 | 2014 | 51 | |
| 13 | 2010 | 34 | |
| 14 | 2014 | 27 | |
| 15 | 2014 | 25 | |
| 16 | 2013 | 11 | |
| 17 | 2021 | 6 | |
| 18 | 2018 | 5 | |
| 19 | 2022 | 2 | |
| 20 | 2014 | 1 |
About Lee B. Rivera
Lee B. Rivera is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Rheumatology, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bone and Dental Protein Studies (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Immune cells in cancer (5 papers), Connective tissue disorders research (3 papers), Cancer Cells and Metastasis (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Oncology (853 citations), Immunology (499 citations), Cancer Research (343 citations), Immunology and Allergy (82 citations) and Molecular Biology (626 citations). Lee B. Rivera has collaborated with scholars based in United States, South Korea and Portugal. Frequent co-authors include Gabriele Bergers, Rolf A. Brekken, Inge Lodewijckx, Rindert Missiaen, Arnaud Jabouille, Veronica Steri, Elizabeth Allen, Douglas Hanahan, Iacovos P. Michael and Amy D. Bradshaw. Their work appears in journals such as Cancer Research, Disease Models & Mechanisms, Science, The Journal of Cell Biology and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.